Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

• Jenny Link ,

  Contributed equally to this work with: Jenny Link, Ryan Ramanujam

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Ryan Ramanujam ,

  Contributed equally to this work with: Jenny Link, Ryan Ramanujam

  Affiliations Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, KTH – Royal Institute of Technology, Stockholm, Sweden

  ⨯
• Michael Auer,

  Affiliation Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Malin Ryner,

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Signe Hässler,

  Affiliation CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France

  ⨯
• Delphine Bachelet,

  Affiliation CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France

  ⨯
• Cyprien Mbogning,

  Affiliation CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France

  ⨯
• Clemens Warnke,

  Affiliation Medical Faculty, Department of Neurology University of Düsseldorf, Düsseldorf, Germany

  ⨯
• Dorothea Buck,

  Affiliation Department of Neurology, Technische Universität München, Munich, Germany

  ⨯
• Poul Erik Hyldgaard Jensen,

  Affiliation Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Claudia Sievers,

  Affiliation University Hospital Basel, Basel, Switzerland

  ⨯
• Kathleen Ingenhoven,

  Affiliation Medical Faculty, Department of Neurology University of Düsseldorf, Düsseldorf, Germany

  ⨯
• Nicolas Fissolo,

  Affiliation Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain

  ⨯
• Raija Lindberg,

  Affiliation University Hospital Basel, Basel, Switzerland

  ⨯
• Verena Grummel,

  Affiliation Department of Neurology, Technische Universität München, Munich, Germany

  ⨯
• Naoimh Donnellan,

  Affiliation Ipsen Biopharm Ltd, Berkshire, United Kingdom

  ⨯
• Manuel Comabella,

  Affiliation Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain

  ⨯
• Xavier Montalban,

  Affiliation Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain

  ⨯
• Bernd Kieseier,

  Affiliation Medical Faculty, Department of Neurology University of Düsseldorf, Düsseldorf, Germany

  ⨯
• Per Soelberg Sørensen,

  Affiliation Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Hans-Peter Hartung,

  Affiliation Medical Faculty, Department of Neurology University of Düsseldorf, Düsseldorf, Germany

  ⨯
• Tobias Derfuss,

  Affiliation University Hospital Basel, Basel, Switzerland

  ⨯
• Andy Lawton,

  Affiliation GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom

  ⨯
• Dan Sikkema,

  Affiliation GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom

  ⨯
• Marc Pallardy,

  Affiliation INSERM UMR 996, Univ. Paris-Sud, Faculty of Pharmacy, Université Paris-Saclay, Châtenay-Malabry, France

  ⨯
• Bernhard Hemmer,

  Affiliation Department of Neurology, Technische Universität München, Munich, Germany

  ⨯
• Florian Deisenhammer,

  Affiliation Innsbruck Medical University, Innsbruck, Austria

  ⨯
• Philippe Broët,

  Affiliations CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France, Assistance Publique - Hôpitaux de Paris, Hôpital Paul Brousse, Villejuif, France

  ⨯
• Pierre Dönnes,

  Affiliation SciCross AB, Skövde, Sweden

  ⨯
• Julie Davidson,

  Affiliation GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom

  ⨯
• Anna Fogdell-Hahn ,

  * E-mail: Anna.Fogdell-Hahn@ki.se

  Affiliation Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  ⨯
•  [ ... ],
• ABIRISK Consortium

  ¶Membership of the ABIRISK Consortium is provided in the S1 File.

  ⨯
• [ view all ]
• [ view less ]